Literature DB >> 6717705

High-density lipoprotein cholesterol in patients with untreated and treated nephrotic syndrome.

I V Sokolovskaya, N V Nikiforova.   

Abstract

Lipids of the blood serum were studied in 29 patients with untreated nephrotic syndrome (NS) and in 28 patients treated with corticosteroids or nonsteroid drugs. None of the patients had evidence of renal failure, either acute or chronic. The patients with untreated NS showed massive proteinuria, marked hypoproteinemia, considerable hypertriglyceridemia and hypercholesterolemia. Serum high-density lipoprotein cholesterol (HDL cholesterol) concentrations were lower in these patients than in the control group, including 35 normal subjects, and correlated with the total serum protein (r = 0.46, p less than 0.05) and serum albumin (r = 0.46, p less than 0.05). An inverse correlation was observed between HDL cholesterol and serum triglyceride levels (r = -0.58, p less than 0.01). In the treated patients the laboratory indices of NS were less pronounced. HDL cholesterol levels were within normal limits in 14 patients with NS treated mostly with nonsteroid drugs, while in the patients receiving the corticosteroids (14 subjects) they were significantly higher than in the control group.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6717705     DOI: 10.1159/000183207

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Serum vitamin A, retinyl esters and vitamin E in nephrotic syndrome.

Authors:  M Mydlík; K Derzsiová; M Brátová; S Havris
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

2.  Effect of methylprednisolone therapy on lipoprotein metabolism in human nephrotic syndrome.

Authors:  L Kuzemková; J Stríbrná; J Kovár; R Poledne; K Matousovic
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

3.  Lipoproteins and cholesterol homeostasis in paediatric nephrotic syndrome patients.

Authors:  Yonas Mulat Simachew; Tamara Antonić; Tamara Gojković; Sandra Vladimirov; Marija Mihajlović; Sanja Vujčić; Gordana Miloševski-Lomić; Jelena Vekić; Aleksandra Zeljković; Vesna Spasojević-Kalimanovska; Amira Peco-Antić; Dušan Paripović; Aleksandra Stefanović
Journal:  Biochem Med (Zagreb)       Date:  2022-06-15       Impact factor: 2.515

Review 4.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01

Review 5.  Hyperlipidemia in childhood nephrotic syndrome.

Authors:  M A Thabet; J R Salcedo; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

Review 6.  Acute myocardial infarction in a young boy with nephrotic syndrome: a case report and review of the literature.

Authors:  L Hopp; N Gilboa; G Kurland; N Weichler; T J Orchard
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

7.  Lipoprotein profiles at different stages of the nephrotic syndrome.

Authors:  U Querfeld; A Gnasso; W Haberbosch; J Augustin; K Schärer
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.